FHL3 and cancer: To investigate the clinical relevance of FHL3 in GC, we systematically analyze multiple publicly available gene expression datasets [The Cancer Genome Atlas/Genotype Tissue Expression (TCGA/GTEx), GSE13861, GSE13911, GSE19826, GSE29998, GSE54129, and GSE63089], which contain >1,000 gastric cancer patients.